company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,33327248.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1301296.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,422185.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,217571.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1077838.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,36346138.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,463340.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095355.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,943466.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,31750.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2070571.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,,totalassets,Total Assets,=,debit,usd,38880049.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2285439.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1140667.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3250516.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6676622.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,869195.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,869195.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,7545817.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,171776289.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-139908525.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-533532.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,31334232.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,31334232.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,31334232.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,,2011-06-30,2011-08-08 17:17:48+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,38880049.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,17118832.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,8996150.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1986786.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,351494.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,255027.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1197331.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,29905620.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,494075.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,6047665.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095355.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,921563.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,31424.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,8096007.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,,totalassets,Total Assets,=,debit,usd,38495702.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1829387.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1652957.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3278789.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6761133.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,839795.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,839795.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,7600928.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,172669465.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-141207784.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-566907.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,30894774.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,30894774.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,30894774.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,,2011-09-30,2011-11-08 17:16:12+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,38495702.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,18167585.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,12026246.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1409006.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1312571.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,253206.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1641208.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,34809822.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,770679.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3006052.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095355.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,976583.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,68023.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,5146013.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,,totalassets,Total Assets,=,debit,usd,40726514.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2927365.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1736572.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3176895.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,7840832.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,790993.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,790993.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,8631825.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,174166626.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-141436109.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-635828.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,32094689.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,32094689.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,32094689.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,,2012-03-31,2012-05-08 16:33:24+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,40726514.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,17973138.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,12024270.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2630275.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,867378.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,460631.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1892218.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,35847910.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1482532.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3019753.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095355.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1043506.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,58485.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,5217099.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,,totalassets,Total Assets,=,debit,usd,42547541.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2617635.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2121121.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2968628.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,7707384.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,471594.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,471594.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,8178978.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,179312517.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-144243181.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-700773.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,34368563.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,34368563.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,34368563.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,,2012-06-30,2012-08-08 16:38:00+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,42547541.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,12159902.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,18051669.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2051344.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,875958.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,983970.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,773129.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,34895972.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3262219.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3019037.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095355.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1173089.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,58553.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,5346034.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,,totalassets,Total Assets,=,debit,usd,43504225.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2819932.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2631445.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1929430.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,7380807.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,452194.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,452194.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,7833001.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,184137917.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-147777420.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-689273.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,35671224.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,35671224.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,35671224.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,,2012-09-30,2012-11-07 16:52:06+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,43504225.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,38126055.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,30154988.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1729232.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,705813.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,688908.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,895562.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,72300558.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4299655.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,12013415.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095355.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1112614.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,61050.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,14282434.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,,totalassets,Total Assets,=,debit,usd,90882647.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3171717.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1758710.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1466020.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6396447.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,913395.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,913395.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,7309842.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,240455118.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-156197613.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-684700.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,83572805.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,83572805.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,83572805.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,,2013-03-31,2013-05-08 16:31:30+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,90882647.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,35914972.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,33099847.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4330136.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1028427.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,868064.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,757037.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,75998483.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5291484.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,6009232.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095355.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1134442.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,61056.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,8300085.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,,totalassets,Total Assets,=,debit,usd,89590052.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5180913.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2782564.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1288212.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9251689.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,893995.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,893995.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,10145684.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,241429026.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-161300869.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-683789.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,79444368.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,79444368.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,79444368.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,,2013-06-30,2013-08-07 16:39:23+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,89590052.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,42960486.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,27053333.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3405395.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1804695.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1001195.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,317514.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,76542618.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6013707.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095355.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1217720.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,61241.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2374316.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,,totalassets,Total Assets,=,debit,usd,84930641.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4689615.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4863980.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,633970.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,10187565.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,874596.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,874596.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,11062161.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,242191484.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-167660826.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-662178.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,73868480.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,73868480.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,73868480.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,,2013-09-30,2013-11-06 17:19:30+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,84930641.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,39057450.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,21002297.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3648162.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,7106012.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,996536.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,545032.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,72355489.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,7632001.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3005066.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095355.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,2124789.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,871460.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,7096670.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,,totalassets,Total Assets,=,debit,usd,87084160.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5679990.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5428622.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,6182342.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,17290954.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,5978654.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,5978654.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,23269608.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,246556109.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-182090546.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-651011.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,63814552.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,63814552.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,63814552.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,,2014-03-31,2014-05-09 17:01:49+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,87084160.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,41017975.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,15004886.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3065166.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,8334688.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1030785.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1062054.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,69515554.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,8613160.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095355.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,2630112.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,871444.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4596911.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,,totalassets,Total Assets,=,debit,usd,82725625.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6461140.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8419221.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,7306921.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,22187282.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,5102111.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,5102111.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,27289393.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,247277795.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-191188271.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-653292.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,55436232.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,55436232.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,55436232.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,,2014-06-30,2014-08-07 16:02:25+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,82725625.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,39050832.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,9003215.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2272373.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,7992961.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,929141.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1689497.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,60938019.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,9668417.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095355.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,2960864.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,871168.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4927387.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,,totalassets,Total Assets,=,debit,usd,75533823.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8030911.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5980708.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,6891503.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,20903122.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,4225568.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,4225568.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,25128690.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,249465251.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-198374712.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-685406.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,50405133.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,50405133.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,50405133.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,,2014-09-30,2014-11-06 16:33:18+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,75533823.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,23543024.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,3001024.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4208270.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,5896998.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3006784.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1708664.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,41364764.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,13105046.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095355.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,2778522.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,326056.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4199933.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,,totalassets,Total Assets,=,debit,usd,58669743.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8852636.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4759033.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,7435518.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,21047187.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2472483.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,2472483.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,23519670.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,251079026.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-215235330.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-693623.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,35150073.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,35150073.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,35150073.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,,2015-03-31,2015-05-11 17:01:42+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,58669743.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,43124635.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,6001895.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,6449885.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,5465568.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2849001.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,943933.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,64834917.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,13558628.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,9016818.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095355.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,2700722.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,326184.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,13139079.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,,totalassets,Total Assets,=,debit,usd,91532624.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4762221.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5657979.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3029854.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,13450054.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,738800.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,738800.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,14188854.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,294763224.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-216741976.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-677478.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,77343770.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,77343770.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,77343770.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,,2015-06-30,2015-08-10 17:03:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,91532624.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,35880958.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,12008939.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,6558074.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,5657336.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2023907.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,519376.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,62648590.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,13831713.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3006531.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095355.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,2551015.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,326024.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,6978925.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,,totalassets,Total Assets,=,debit,usd,83459228.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2392929.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5745440.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1980710.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,10119079.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,719400.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,719400.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,10838479.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,295800288.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-222480017.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-699522.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,72620749.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,72620749.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,72620749.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,,2015-09-30,2015-11-05 17:03:26+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,83459228.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,30102144.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,12009000.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,7976760.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,5270049.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3178256.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,2049330.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,60585539.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,17142571.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095355.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,2331347.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,153826.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3580528.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,,totalassets,Total Assets,=,debit,usd,81308638.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6960444.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8530420.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,5254028.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,20744892.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,680600.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,680600.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,21425492.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,297342241.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-236762612.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-696483.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,59883146.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,59883146.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,59883146.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,,2016-03-31,2016-05-09 16:55:11+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,81308638.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,27559208.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,9004427.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,10295347.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,7458933.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2716391.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,2141280.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,59175586.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,17356620.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095355.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,2224881.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,153762.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3473998.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,,totalassets,Total Assets,=,debit,usd,80006204.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,10825215.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6958452.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,6494770.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,24278437.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1200000.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1200000.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,25478437.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,298054080.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-242824075.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-702238.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,54527767.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,54527767.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,54527767.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,,2016-06-30,2016-08-09 15:00:02+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,80006204.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,28781427.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,3001312.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,8561738.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,6723555.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,376212.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1961630.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,49405874.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,17993431.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095355.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,2149225.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,153800.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3398380.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,,totalassets,Total Assets,=,debit,usd,70797685.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8096400.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6656351.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,5801902.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,20554653.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1200000.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1200000.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,21754653.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,298687696.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-248945058.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-699606.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,49043032.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,49043032.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,49043032.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,,2016-09-30,2016-11-09 16:01:11+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,70797685.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,23677111.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,7884665.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,6852386.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1520125.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1712139.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,41646426.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,17607938.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095355.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1924619.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,53675.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3073649.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,,totalassets,Total Assets,=,debit,usd,62328013.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8687427.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7108360.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3928590.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,19724377.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1200000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1200000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,20924377.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,300391974.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-258278409.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-709929.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,41403636.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,41403636.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,41403636.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,,2017-03-31,2017-05-09 16:42:12+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,62328013.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,33418393.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,9960479.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,9067689.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,7845547.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1690036.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,893619.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,62875763.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,17550876.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095355.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1766830.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,53847.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2916032.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,,totalassets,Total Assets,=,debit,usd,83342671.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8478038.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6172077.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3483297.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,18133412.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,24724304.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,200000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,24924304.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,43057716.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,302100382.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-261118353.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-697074.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,40284955.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,40284955.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,40284955.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,,2017-06-30,2017-08-08 16:28:45+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,83342671.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,27433489.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,9976984.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,10146966.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,7942376.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1680208.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1213507.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,58393530.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,17296719.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095355.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1630785.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,53778.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2779918.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,,totalassets,Total Assets,=,debit,usd,78470167.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8245154.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6394379.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2842801.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,17482334.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,24791214.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,200000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,24991214.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,42473548.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,303268188.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-266570874.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-700695.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,35996619.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,35996619.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,35996619.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,,2017-09-30,2017-11-07 16:52:52+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,78470167.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,23111000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,4997000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,12494000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,9929000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2074000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,432000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,53037000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,15892000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1267000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,148000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2510000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,,totalassets,Total Assets,=,debit,usd,71439000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6652000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6868000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1797000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2750000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,18067000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,24925000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,200000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,25125000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,43192000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,305415000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-276478000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-690000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,28247000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,28247000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,28247000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,,2018-03-31,2018-05-08 16:01:10+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,71439000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,28782000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,14072000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,10680000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1915000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,411000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,55860000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,15569000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1133000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,148000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2376000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,,totalassets,Total Assets,=,debit,usd,73805000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6577000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9063000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,827000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,7500000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,23967000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,24992000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,200000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,25192000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,49159000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,306344000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-280998000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-700000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,24646000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,24646000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,24646000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,,2018-06-30,2018-08-07 16:30:16+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,73805000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,28160000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,15483000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,11275000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1806000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,275000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,56999000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,15325000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,998000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,148000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2241000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,,totalassets,Total Assets,=,debit,usd,74565000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7497000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9124000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,811000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,7500000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,24932000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,25059000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,200000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,25259000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,50191000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,308010000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-282934000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-702000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,24374000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,24374000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,24374000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,,2018-09-30,2018-11-06 16:42:49+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,74565000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,23238000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,29772000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,13378000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3657000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,9445000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,79490000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,15100000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,688000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2412000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4195000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,,totalassets,Total Assets,=,debit,usd,98785000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,4933000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,15622000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,11844000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1537000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,866000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,34802000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,20260000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1055000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,21315000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,56117000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,325597000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-282223000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-706000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,42668000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,42668000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,42668000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,,2019-03-31,2019-05-02 16:28:43+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,98785000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,40171000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,24629000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,15235000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2781000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,6285000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,89101000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,14994000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,556000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,3466000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,5117000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,,totalassets,Total Assets,=,debit,usd,109212000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,11699000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12571000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,547000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,961000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,25778000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,40143000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1739000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,41882000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,67660000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,326705000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-284449000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-704000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,41552000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,41552000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,41552000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,,2019-06-30,2019-08-06 16:01:33+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,109212000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,41874000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,33931000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,16503000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1429000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,6199000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,99936000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,15409000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1095000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,508000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5981000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,7584000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,,totalassets,Total Assets,=,debit,usd,122929000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,16530000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,14966000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1412000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,975000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,33883000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,40269000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,4362000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,44631000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,78514000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,328527000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-283406000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-706000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,44415000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,44415000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,44415000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,,2019-09-30,2019-11-05 16:14:57+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,122929000.0
